Drug-induced liver injury: an overview over the most critical compounds
- PMID: 25618544
- DOI: 10.1007/s00204-015-1456-2
Drug-induced liver injury: an overview over the most critical compounds
Abstract
There has been a substantial interest in drug-induced liver injury (DILI) recently. National Institutes of Health has sponsored a multicenter study in the USA for the last 10 years, which has collected valuable information in this context. Idiosyncratic DILI is like other adverse effects of drugs underestimated and underreported in most epidemiological studies. A recent prospective population-based study from Iceland found a crude incidence of approximately 19 cases per 100,000 and year. Antibiotic is the class of drugs most commonly implicated in patients with DILI. Amoxicillin-clavulanate continues to be the most commonly implicated agent occurring in approximately 1 out of 2,300 users. Drugs with the highest risk of DILI in the Icelandic study were azathioprine and infliximab. Although rare, statin-induced hepatotoxicity has been well documented. Liver injury associated with the use of herbal medicines and dietary supplements seems to be increasing. Information on the documented hepatotoxicity of drugs has recently been made easier by a website available in the public domain: LiverTox ( http://livertox.nlm.nih.gov ). Unfortunately, at the current time, pre-therapy risk assessment for DILI in the individual patient is difficult but previous well-documented hepatotoxicity is usually a contraindication for a subsequent treatment with the same drug.
Similar articles
-
Hepatotoxicity by Drugs: The Most Common Implicated Agents.Int J Mol Sci. 2016 Feb 6;17(2):224. doi: 10.3390/ijms17020224. Int J Mol Sci. 2016. PMID: 26861310 Free PMC article. Review.
-
Incidence, presentation, and outcomes in patients with drug-induced liver injury in the general population of Iceland.Gastroenterology. 2013 Jun;144(7):1419-25, 1425.e1-3; quiz e19-20. doi: 10.1053/j.gastro.2013.02.006. Epub 2013 Feb 16. Gastroenterology. 2013. PMID: 23419359
-
Adverse drug reactions and organ damage: The liver.Eur J Intern Med. 2016 Mar;28:9-16. doi: 10.1016/j.ejim.2015.12.017. Epub 2016 Jan 28. Eur J Intern Med. 2016. PMID: 26827101 Review.
-
Epidemiology and risk factors for idiosyncratic drug-induced liver injury.Semin Liver Dis. 2014 May;34(2):115-22. doi: 10.1055/s-0034-1375953. Epub 2014 May 31. Semin Liver Dis. 2014. PMID: 24879977 Review.
-
An update on drug induced liver injury.Minerva Gastroenterol Dietol. 2011 Jun;57(2):213-29. Minerva Gastroenterol Dietol. 2011. PMID: 21587150 Review.
Cited by
-
Drug-induced liver injury associated with Complementary and Alternative Medicine: a review of adverse event reports in an Asian community from 2009 to 2014.BMC Complement Altern Med. 2016 Jul 7;16:192. doi: 10.1186/s12906-016-1168-z. BMC Complement Altern Med. 2016. PMID: 27389194 Free PMC article.
-
From pharmacogenetics to pharmaco-omics: Milestones and future directions.HGG Adv. 2022 Mar 16;3(2):100100. doi: 10.1016/j.xhgg.2022.100100. eCollection 2022 Apr 14. HGG Adv. 2022. PMID: 35373152 Free PMC article. Review.
-
Investigation of the idiosyncratic hepatotoxicity of Polygonum multiflorum Thunb. through metabolomics using GC-MS.BMC Complement Med Ther. 2021 Apr 12;21(1):120. doi: 10.1186/s12906-021-03276-4. BMC Complement Med Ther. 2021. PMID: 33845816 Free PMC article.
-
Autophagy alleviates amiodarone-induced hepatotoxicity.Arch Toxicol. 2020 Oct;94(10):3527-3539. doi: 10.1007/s00204-020-02837-9. Epub 2020 Jul 10. Arch Toxicol. 2020. PMID: 32651653 Free PMC article.
-
Pathophysiology of cholestatic liver disease and its relevance for in vitro tests of hepatotoxicity.EXCLI J. 2016 Dec 23;15:870-871. doi: 10.17179/excli2016-864. eCollection 2016. EXCLI J. 2016. PMID: 28275322 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
